(Q44638430)

4 December 2017

Cardiovascular risk factors in overweight and obesity. Changes after a weight loss treatment (English)

1 reference

4 December 2017

0 references

4

1 reference

José Alberto Montoya-Alonso

4 December 2017

object named as

José Alberto Montoya-Alonso

series ordinal

3

0 references

author name string

Inmaculada Bautista-Castaño

series ordinal

1

1 reference

4 December 2017

Jesús Molina-Cabrillana

series ordinal

2

1 reference

4 December 2017

language of work or name

Spanish

0 references

publication date

1 October 2003

1 reference

4 December 2017

1 reference

4 December 2017

121

1 reference

4 December 2017

13

1 reference

4 December 2017

485-491

1 reference

Obesity prevention: the case for action

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

A prospective study of obesity and risk of coronary heart disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Obesity and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Report of a National Institutes of Health--Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Effects of body weight control on changes in blood pressure: three-year follow-up study in young Japanese individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Risk factors for coronary heart disease in obese non-diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Body mass index and the prevalence of hypertension and dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Adiposity indices and their relationship with some risk factors of coronary heart disease in middle-aged Cambridge men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Association between simple anthropometric indices and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Obesity and disease management: effects of weight loss on comorbid conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Cardiovascular risk factors in patients with morbid obesity: weight loss influence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Body weight and blood pressure regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

The Effects on Plasma Lipoproteins of a Prudent Weight-Reducing Diet, with or without Exercise, in Overweight Men and Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Physical activity, obesity and blood lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Changes in plasma lipids and other cardiovascular risk factors during 3 energy-restricted diets differing in total fat and fatty acid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973997-9

10.1016/S0025-7753(03)73997-9

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference